川崎病合并巨噬细胞活化综合征1例并文献复习
One Case of Kawasaki Disease Complicated with Macrophage Activation Syndrome and Literature Review
DOI: 10.12677/acm.2024.1492427, PDF,   
作者: 张淑红, 张兰华, 刘旖旎:山东大学附属威海市立医院儿科,山东 威海
关键词: 川崎病儿童巨噬细胞活化综合征Kawasaki Disease Children Macrophage Activation Syndrome
摘要: 目的:总结1例川崎病合并巨噬细胞活化综合征患儿的临床特点及诊疗经过,提高对该疾病的认识。方法:回顾性分析2023年1月山东大学附属威海市立医院儿科收治的1例川崎病合并巨噬细胞活化综合征患儿的临床特点及诊疗经过,并进行相关文献复习。结果:患儿以发热、皮疹及结膜充血为突出表现,在诊断为川崎病后使用静注人免疫球蛋白、阿司匹林治疗,仍高热。加用糖皮质激素后体温降至正常,结合相关检查,诊断KD合并MAS。结论:对于川崎病患儿,若伴有三系减少或静注人免疫球蛋白治疗无效时,应考虑是否合并MAS,及时加用糖皮质激素,降低死亡率。
Abstract: Objective: To summarize the clinical characteristics and treatment outcome of 1 cases of Kawasaki disease complicated by macrophage activation syndrome so as to improve clinician’s awareness of the disease. Methods: Retrospective analysis of the clinical characteristics and diagnosis and treatment process of a child with Kawasaki disease complicated with macrophage activation syndrome admitted to the pediatrics department of Weihai Municipal Hospital affiliated with Shandong University in January 2023, and relevant literature review. Results: The child presented with prominent symptoms of fever, rash, and conjunctival congestion. After diagnosis of Kawasaki disease, intravenous immunoglobulin and aspirin were used for treatment, but the fever persisted. After adding glucocorticoids, the body temperature returned to normal, and combined with relevant examinations, KD was diagnosed with MAS. Conclusions: For children with Kawasaki disease, if there is a reduction in the three lineages or if intravenous immunoglobulin therapy is ineffective, consideration should be given to whether to combine MAS and timely use of glucocorticoids to reduce mortality.
文章引用:张淑红, 张兰华, 刘旖旎. 川崎病合并巨噬细胞活化综合征1例并文献复习[J]. 临床医学进展, 2024, 14(9): 54-57. https://doi.org/10.12677/acm.2024.1492427

参考文献

[1] Alongi, A., Naddei, R., De Miglio, L., Natoli, V. and Ravelli, A. (2020) Macrophage Activation Syndrome in Pediatrics. Pediatric Allergy and Immunology, 31, 13-15. [Google Scholar] [CrossRef] [PubMed]
[2] Wang, W., Gong, F., Zhu, W., Fu, S. and Zhang, Q. (2015) Macrophage Activation Syndrome in Kawasaki Disease: More Common than We Thought? Seminars in Arthritis and Rheumatism, 44, 405-410. [Google Scholar] [CrossRef] [PubMed]
[3] Choi, J.E., Kwak, Y., Huh, J.W., Yoo, E., Ryu, K., Sohn, S., et al. (2018) Differentiation between Incomplete Kawasaki Disease and Secondary Hemophagocytic Lymphohistiocytosis Following Kawasaki Disease Using N-Terminal Pro-Brain Natriuretic Peptide. Korean Journal of Pediatrics, 61, 167-173. [Google Scholar] [CrossRef] [PubMed]
[4] García-Pavón, S., Yamazaki-Nakashimada, M.A., Báez, M., Borjas-Aguilar, K.L. and Murata, C. (2017) Kawasaki Disease Complicated with Macrophage Activation Syndrome: A Systematic Review. Journal of Pediatric Hematology/Oncology, 39, 445-451. [Google Scholar] [CrossRef] [PubMed]
[5] Avčin, T., Tse, S.M.L., Schneider, R., Ngan, B. and Silverman, E.D. (2006) Macrophage Activation Syndrome as the Presenting Manifestation of Rheumatic Diseases in Childhood. The Journal of Pediatrics, 148, 683-686. [Google Scholar] [CrossRef] [PubMed]
[6] Henter, J., Horne, A., Aricó, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., et al. (2006) HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131. [Google Scholar] [CrossRef] [PubMed]
[7] 汪顺雨, 刘庚英, 杜忠东, 等. 川崎病合并巨噬细胞活化综合征的临床研究进展[J]. 中华儿科杂志, 2020, 58(11): 953-956.
[8] Zou, L., Zhu, Y., Sun, L., Ma, H., Yang, S., Zeng, H., et al. (2019) Clinical and Laboratory Features, Treatment, and Outcomes of Macrophage Activation Syndrome in 80 Children: A Multi-Center Study in China. World Journal of Pediatrics, 16, 89-98. [Google Scholar] [CrossRef] [PubMed]
[9] Liu, F.F., Wang, J.J., Wu, Y., Liu, H.H. and Hu, P. (2019) Complete Atrioventricular Block and Macrophage Activation Syndrome Simultaneously Occurred in a 6-Year-Old Chinese Girl with Kawasaki Disease. JCR: Journal of Clinical Rheumatology, 26, e324-e325. [Google Scholar] [CrossRef] [PubMed]
[10] Jin, P., Luo, Y., Liu, X., Xu, J. and Liu, C. (2019) Kawasaki Disease Complicated with Macrophage Activation Syndrome: Case Reports and Literature Review. Frontiers in Pediatrics, 7, Article 423. [Google Scholar] [CrossRef] [PubMed]
[11] Kounami, S., Yoshiyama, M., Nakayama, K., Okuda, M., Okuda, S., Aoyagi, N., et al. (2005) Macrophage Activation Syndrome in Children with Systemic-Onset Juvenile Chronic Arthritis. Acta Haematologica, 113, 124-129. [Google Scholar] [CrossRef] [PubMed]
[12] Kelly, A. and Ramanan, A.V. (2007) Recognition and Management of Macrophage Activation Syndrome in Juvenile Arthritis. Current Opinion in Rheumatology, 19, 477-481. [Google Scholar] [CrossRef] [PubMed]
[13] Ravelli, A., Davì, S., Minoia, F., Martini, A. and Cron, R.Q. (2015) Macrophage Activation Syndrome. Hematology/Oncology Clinics of North America, 29, 927-941. [Google Scholar] [CrossRef] [PubMed]